Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort Study.
Cheli Melzer CohenNino HallénGabriel ChodickLotmit BourvineTal WanerAvraham KarasikPublished in: PharmacoEconomics - open (2021)
Our results indicate that CV complications of T2D place a substantial excess economic burden on Israel's healthcare system over the short term (up to 12 months).